The status as related to pyruvate level measured from the specimen's blood serum/plasma sample.
Registration Status:
Qualified
Permissible Values:
Data Type:
Value List
Unit of Measure:
Ids:
Value
Code Name
Code
Code System
Code Description
Increase in pyruvate
Increase in pyruvate
Increase in pyruvate
Normal pyruvate
Normal pyruvate
Normal pyruvate
Decrease in pyruvate
Decrease in pyruvate
Decrease in pyruvate
Designations:
Designation:
Blood specimen pyruvate measurement status
Tags:
Designations:
Definition:
The status as related to pyruvate level measured from the specimen's blood serum/plasma sample.
Tags:
Reference Documents:
ID:
Title:
URI:
Provider Org:
Language Code:
Document:
"Suomalainen, A., Biomarkers For Mitochondrial Respiratory Chain Disorders. J Inherit Metab Dis, 2011. 34(2): P. 277-82. Haas, R.H., et al., Mitochondrial Disease: A Practical Approach for Primary Care Physicians. Pediatrics, 2007. 120(6): P. 1326-33. Mancuso, M., et al., Diagnostic Approach to Mitochondrial Disorders: The Need for a Reliable Biomarker. Curr Mol Med, 2009. 9(9): P. 1095-107. Davis, R.L., et al., Fibroblast Growth Factor 21 is a Sensitive Biomarker of Mitochondrial Disease. Neurology, 2013. 81(21): P. 1819-26."